Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.47 (
cysteine synthase
)
625
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A number of metabolizing systems are measured in normal, preneoplastic and neoplastic mouse mammary tissues derived under three different conditions. These biochemical functions are considered to be important in the activation and detoxification of carcinogens and other xenobiotics and have been linked to the process of rat liver hepatocarcinogenesis. The cytochrome P450-dependent enzyme aminopyrine N-demethylase, consistently depressed in hepatocarcinogenesis models in mouse and rat, does not show a significant change among normal, preneoplastic and neoplastic mammary tissues. Glutathione and the enzymes of glutathione metabolism and utilization (e.g. glutathione-S-transferases and gamma-glutamyl transferase), active in the detoxification of xenobiotics, show no significant differences in carcinogen-induced tumors or in their homologous preneoplasias compared to control tissue. There is no increase in the anionic glutathione-S-transferase, a principal marker in rat hepatocarcinogenesis. The only observed biochemical change was a significant decrease in gamma-glutamyl
cysteine synthetase
the glutathione synthetic enzyme, in the carcinogen-induced preneoplastic and neoplastic line compared to control. Also inorganic glutathione peroxidase was lower in the preneoplastic, but not in the neoplastic tissues.
Carcinogenesis
1989 Dec
PMID:Biochemical characteristics of mouse mammary tissues, preneoplastic lesions and tumors. 257 78
It has been widely recognized that induction of Phase 2 enzymes is an effective and sufficient strategy for achieving protection against
carcinogenesis
. Nrf2 is the unifying master regulator of these enzymes and its activation in various tissues, including the urinary bladder, is associated with inhibition of
carcinogenesis
. 5,6-Dihydrocyclopenta[c][1,2]-dithiole-3(4H)-thione (CPDT) is a highly potent inducer of Phase 2 enzymes and an activator of Nrf2. In vivo, it is particularly effective in the bladder, showing significant effects in this tissue when dosed to rats at levels as low as 0.98 micromol/(kgday) (0.17 mg/(kg day)). The activities of key Phase 2 enzymes, including glutathione S-transferase, NAD(P)H:quinone:oxidoreductase 1 and glutamate
cysteine synthetase
, and levels of glutathione were elevated by CPDT in rat bladder in vivo and in cultured bladder cells in vitro. In the bladder, enzyme induction and Nrf2 activation appear to occur exclusively in the epithelium. This is highly significant, since almost all bladder cancers develop from the epithelium. Studies in cultured bladder cells using siRNA to knock down Nrf2 or in cells with total Nrf2 knockout showed that the ability of CPDT to induce Phase 2 enzymes depends completely on Nrf2. In conclusion, CPDT potently and preferentially induces Phase 2 enzymes in the bladder epithelium and Nrf2 is its key mediator.
...
PMID:5,6-Dihydrocyclopenta[c][1,2]-dithiole-3(4H)-thione is a promising cancer chemopreventive agent in the urinary bladder. 1912 Dec 94
Colorectal cancer (CRC) is a major cause of tumor-related morbidity and mortality worldwide. Recent research suggests that pharmacological intervention using dietary factors that activate the redox sensitive Nrf2/Keap1-ARE signaling pathway may represent a promising strategy for chemoprevention of human cancer including CRC. In our search for dietary Nrf2 activators with potential chemopreventive activity targeting CRC, we have focused our studies on trans-cinnamic aldehyde (cinnamaldeyde, CA), the key flavor compound in cinnamon essential oil. Here we demonstrate that CA and an ethanolic extract (CE) prepared from Cinnamomum cassia bark, standardized for CA content by GC-MS analysis, display equipotent activity as inducers of Nrf2 transcriptional activity. In human colon cancer cells (HCT116, HT29) and non-immortalized primary fetal colon cells (FHC), CA- and CE-treatment upregulated cellular protein levels of Nrf2 and established Nrf2 targets involved in the antioxidant response including heme oxygenase 1 (HO-1) and gamma-glutamyl-
cysteine synthetase
(gamma-GCS, catalytic subunit). CA- and CE-pretreatment strongly upregulated cellular glutathione levels and protected HCT116 cells against hydrogen peroxide-induced genotoxicity and arsenic-induced oxidative insult. Taken together our data demonstrate that the cinnamon-derived food factor CA is a potent activator of the Nrf2-orchestrated antioxidant response in cultured human epithelial colon cells. CA may therefore represent an underappreciated chemopreventive dietary factor targeting colorectal
carcinogenesis
.
...
PMID:The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells. 2065 84